Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
about
Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotininDiffuse panbronchiolitis and cystic fibrosis: East meets WestRole of oxidants in microbial pathophysiologyState of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and functionInfluence of neutrophil defects on Burkholderia cepacia complex pathogenesis.Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4.Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?Alveolar inflammation in cystic fibrosis.A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.Neutrophil elastase contributes to acute lung injury induced by bilateral nephrectomy.Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.Inflammation and cystic fibrosis pulmonary disease.The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation.Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection.Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.Transfer of a constitutive viral promoter-cystic fibrosis transmembrane conductance regulator cDNA to human epithelial cells conveys resistance to down-regulation of cAMP-regulated Cl- secretion in the presence of inflammatory stimuli.Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cellsRandomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis.Lung infections. 3. Pseudomonas aeruginosa and other related species.Assessment of airway neutrophils by sputum colour: correlation with airways inflammation.Chlamydia trachomatis growth stimulates interleukin 8 production by human monocytic U-937 cells.Nitrite reductase from Pseudomonas aeruginosa induces inflammatory cytokines in cultured respiratory cells.Potential of anti-inflammatory treatment for cystic fibrosis lung disease.Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.Antiinflammatory therapies for cystic fibrosis: past, present, and future.Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophilsIn vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2Sputum biomarkers of inflammation in cystic fibrosis lung diseaseInnate host defense functions of secretory leucoprotease inhibitor.Secretory leukocyte peptidase inhibitor and lung cancer.Barrier function of airway tract epitheliumAntineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors.Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.
P2860
Q24534158-0A24523A-B20E-45A3-A699-F288656A614CQ24561380-18B8ACB7-0439-4136-8971-3E5555635984Q24683780-CE46CACB-21CF-429A-AE72-52F01BF9FD3AQ24802489-3D86E37A-84C6-4591-91A5-0DAFAA2F1E17Q26799406-07991319-A675-4FF0-88F0-1D0FC7BC47ABQ30425441-3B8F2E6D-1DDB-41DB-A883-59EC79067761Q31144337-3DB7264B-1350-4E99-BC9E-B1827F4A7223Q33180176-C246F6FA-4014-4BF8-869A-DE25FC6D7279Q33775986-0E68A4B1-83F4-4235-9876-D24BAC78C11AQ33855072-B185BFD5-0DFB-432D-8084-EAAA6295B8A1Q33905883-8E11CF84-C03A-4F04-8992-653E980204C4Q34047949-BC381D42-A563-4D9B-9A49-B85D488AA9BEQ34162310-663464E0-CF8B-4542-8E85-F6609B61412EQ34236026-995A3BE8-BFDF-4617-AA6A-F94DE94C5937Q34249405-B584908C-A410-40AD-9448-97D3420705C6Q34330083-43319C18-742C-4CC8-A09F-133C3E4478F1Q34348149-570ECA58-15ED-4DC6-A761-E850A7F05765Q34532344-DAA74B0C-84B9-43E8-AD5A-BE05022124F1Q34539393-E77BCA6A-1D61-4039-92ED-EEE23BDAE290Q34889409-23EA85A0-0E61-4E79-AE1F-EDCD723752E9Q35022070-F230D7B3-118E-4732-B277-51CFDAD7B675Q35256369-AA4940D5-147B-44DC-BCEA-70CD000E6BF7Q35532283-83231DD5-76AD-451E-939F-16E79DC8B221Q35534495-9AFF66C9-1759-4AE8-AFE8-E83D53B3FDB1Q35549782-ACD33A6A-F86D-4E2C-A610-50D167C6F626Q35550634-6261AAA6-AE53-420E-90F8-D93F5C9707C3Q35557381-BD2B9A12-C81A-483E-8FB8-5155BAF8F93BQ35597064-A8B81A81-5A27-4D26-8BB4-DF7B002ACF5BQ36032652-95472148-A13A-4F6D-B969-BABB64C1A03DQ36114167-29E037C0-7DA6-44E6-AC3A-28B8E7FB82F5Q36174470-772472B3-ED29-4F74-8803-24280FAC1F9DQ36236365-E2C80B87-2FA8-43D5-A752-0673664C07A5Q36711493-E2A7B1D2-F1E5-44D5-85AD-A40D16D036C2Q36891552-CB5DCB76-3A8B-4575-9186-8E39C460BAD0Q37030651-5ACF39CD-69E9-4B24-A366-BFF788B6B47EQ37124951-14F78AFF-BF79-4328-A1AD-B7A1ABDA4EBFQ37197947-E1960CD5-FE80-47C7-978E-CF51B578B22EQ37372478-358F2DC2-36AB-49DE-8402-7EC30C67E517Q37447482-8722D3CF-7A58-44A0-8E89-A711F3F48B19Q37731798-49F8289D-3B3F-4251-9E28-B496338F8F97
P2860
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Modulation of airway inflammat ...... etory leukoprotease inhibitor.
@ast
Modulation of airway inflammat ...... etory leukoprotease inhibitor.
@en
type
label
Modulation of airway inflammat ...... etory leukoprotease inhibitor.
@ast
Modulation of airway inflammat ...... etory leukoprotease inhibitor.
@en
prefLabel
Modulation of airway inflammat ...... etory leukoprotease inhibitor.
@ast
Modulation of airway inflammat ...... etory leukoprotease inhibitor.
@en
P2093
P2860
P356
P1476
Modulation of airway inflammat ...... etory leukoprotease inhibitor.
@en
P2093
Alphonso M
Catalano MA
Crystal RG
McElvaney NG
Nakamura H
P2860
P304
P356
10.1172/JCI115994
P407
P577
1992-10-01T00:00:00Z